Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sunil Nayak

Pediatric Endocrinology Greenwood Village, CO Medical Doctor

NPI 1528166923 CMS profile 1260172

8200 E Belleview Ave, #510E, Greenwood Village, CO 80111

Open in the dashboard

General payments

$14,254

161 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$695,480 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Sunil Nayak of Greenwood Village, CO is reported in the CMS Open Payments database as having received $14,254 across 161 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $695,480 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 84th percentile of Pediatric Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,116 41
2024 General $635 25
2023 General $497 17
2022 General $490 19
2021 General $6,126 33
2020 General $3,123 16
2019 General $2,267 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sunil Nayak
  • Pediatric Endocrinology median
  • Middle half of Pediatric Endocrinology
  • National median

In program year 2025, general payments to Sunil Nayak were reported at $1,116. Among 971 Pediatric Endocrinology profiles paid that year, the median was $293 and the middle half received between $106 and $1,640.

Show as a table
Year Sunil Nayak Pediatric Endocrinology median Middle half National median
2019 $2,267 $196 $68–$845 $163
2020 $3,123 $124 $37–$722 $114
2021 $6,126 $134 $35–$691 $132
2022 $490 $177 $47–$726 $149
2023 $497 $236 $75–$887 $160
2024 $635 $259 $91–$979 $164
2025 $1,116 $293 $106–$1,640 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Tandem Diabetes Care, Inc. $9,763 39 payments
  2. Pfizer Inc. $1,245 15 payments
  3. Novo Nordisk Inc $613 19 payments
  4. Ascendis Pharma, Inc. $486 13 payments
  5. Abbott Laboratories $294 6 payments
  6. AbbVie, Inc. $279 11 payments
  7. Amphastar Pharmaceuticals, Inc. $267 7 payments
  8. Beta Bionics, Inc. $206 5 payments
  9. Medtronic MiniMed, Inc. $170 3 payments
  10. Sanofi-Aventis U.S. LLC $160 7 payments
  11. Other $771 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,650 35 payments
  2. Food and Beverage $3,660 120 payments
  3. Travel and Lodging $736 3 payments
  4. Education $209 3 payments
Products named General payments · program years 2019–2025
  1. t-slim insulin pump Endocrinology $5,550 20 payments
  2. t:slim X2 insulin pump $3,000 11 payments
  3. GENOTROPIN $1,101 10 payments
  4. t-slim insulin pump Endocrinology $1,100 4 payments
  5. SKYTROFA $486 13 payments
  6. Norditropin $325 11 payments
  7. Sogroya $288 8 payments
  8. BAQSIMI $267 7 payments
  9. LUPRON DEPOT $235 9 payments
  10. Freestyle CoPilot Health Management System $200 1 payment
  11. Other $2,428 87 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

161 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Endocrinology in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record